Pfizer

Eli Lilly Broadens Diabetes Offer

Big Drugmakers Think Small with Nanomedicine Deals

Strong Pet Product Sales Help Zoetis Top Estimates

Pfizer Q1 Results Fall Short

Merck, Pfizer to Jointly Develop Diabetes Drug

AbbVie Delivers on Scorching Humira Drug Sales Growth

Optimer Shares Rise After Report Names Glaxo, Cubist as Potential Buyers

Novartis Loses Landmark India Cancer Drug Patent Case

Pfizer Fails to End Lawsuit Over Bextra, Celebrex Safety

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

Pfizer Gets Celebrex Patent Extension

Generics Brought Down Common Drug Prices in 2012

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Obama Medicare Rebate Plan Could Hurt Drug Companies

Amgen Biosimilar Push Takes Aim at Blockbusters

Buyers Eye Multibillion Deal for Brazilian Drugmaker

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

AbbVie Forecasts Slower Humira Growth

Pfizer Q4 Results Top Forecast

China to Cut Prices of More than 400 Drugs from February

Italy's Philogen Signs Drug License Deal with Pfizer

Entering the Age of the $1 Million Medicine

US FDA New Drug Approvals Hit 16-Year High in 2012

FDA Approves Bristol Myers, Pfizer's Anti-Clotting Drug Eliquis

Mitsubishi Chem to Buy Capsule Maker from Carlyle

Eli Lilly to Pay $29 Million to Settle US SEC Bribery Case

Drug Industry Treading Water on R&D Productivity

Ranbaxy Halts Generic Lipitor Production After Recall

Canada's Supreme Court Strips Viagra Patent from Pfizer

Pfizer Quarterly Revenue Fall Far Short of Forecasts

Nestle Names Cantarell Head of Nutrition Unit

US Foreign Bribery Penalties for Drugmakers May Lack Bite

GSK Raises Bet on AIDS Drug with New Shionogi Deal

Amgen Q3 Profits Up

68 more articles

Top-Feature

Leading Transformation

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Brenntag Downsizes Management Board, Retains Both Divisions

Dow Chemical Company

Anchored in Sustainability

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Easyfairs Deutschland GmbH

Leading the way. Driving results.

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.